Atomic AI
@AtomicAICo
Followers
984
Following
56
Media
66
Statuses
121
At Atomic AI, we are developing the cutting-edge fusion of machine learning and structural biology to unlock RNA drug discovery.
Joined December 2022
At Atomic AI we are enabling AI-driven RNA drug discovery, with atomic precision. To learn more and apply check out our job board: https://t.co/1qsSMVtYd1
job-boards.greenhouse.io
Atomic AI, Inc. is a well-funded, early-stage biotech company transforming the rational design of molecules and medicines through the cutting-edge fusion of artificial intelligence and structural...
2
5
12
Thrilled to share that our Founder & CEO Raphael Townshend @raphaeljlt has been named to @BioSpace’s inaugural 𝟰𝟬 𝗨𝗻𝗱𝗲𝗿 𝟰𝟬 list! 🎉 Honored to see his leadership in fusing AI + RNA structural biology recognized among biotech’s brightest. 👉 https://t.co/tNVJYkQVfr
0
0
3
With just four bases, it seems RNA would be easy to work with. Far from it. Its structural flexibility adds a level of complexity that is difficult to overcome. Hear how our platform is doing just that, and redefining RNA #drugdiscovery in the process.
linkedin.com
Login to LinkedIn to keep in touch with people you know, share ideas, and build your career.
1
0
3
Mark Stead worked in RNA biology before it was cool. Now, as Head of Discovery and Business Development, he helps lead Atomic AI. What inspired him to move from the bench into business? Hear about it here with @TalentOracle. 📺 Watch on demand:
linkedin.com
Login to LinkedIn to keep in touch with people you know, share ideas, and build your career.
0
0
3
Messy but meaningful, folded but functional. Today, we celebrate the squiggly, strange, and spectacular molecule changing the future of drug discovery. Happy #RNADay from all of us at Atomic AI!
0
1
6
Join Atomic AI at #BIO2025 in Boston! We’re excited to be part of the panel: 🧬 “Integrating AI-Driven Drug Discovery to Improve R&D Supply Chain Efficiency” 📆 June 16 | 3–4 PM 📍 254B https://t.co/Wrnqfdzxsv
0
0
3
Join @raphaeljlt at #SCSPAIExpo2025 on Jun 2nd where industry, academia, and govt come together to explore and demo emerging tech. 10:10 AM – Tech talk on AI + RNA drug design 2:50 PM – Panel on accelerating drug discovery w/AI 🔗
expo.scsp.ai
Join members of government, academia, and tech in the nation’s capital to forge the future of AI and emerging technology leadership.
Registration for the AI+ Expo is now live! Join us on June 2-4 in Washington, DC where we will bring together industry, academia, and the public sector for three days of exploring the latest advancements in emerging technology, critical discussions, demos, and so much more. Visit
0
0
1
“RNA remains a black box—especially structurally. While we know around 7,000 protein structures out of 20,000 in humans, we only have 100 RNA structures out of 100,000 possible transcripts. That gap in understanding is exactly why many algorithms struggle to predict RNA shape.”
1
2
9
Could reprogramming RNA splicing to trigger a premature stop codon—and thereby reduce the production of a key cancer-driving protein—unlock a new frontier in cancer treatment? Learn about ATM-5292, an orally available small molecule targeting two key oncogenes, at #AACR25.
0
0
3
In Singapore for #ICLR2025? Be sure to catch the @ai4na_workshop on Monday, featuring a talk from our head of machine learning, Stephan Eismann. https://t.co/BBzdc3SLrR
0
0
3
Raphael Townshend @raphaeljlt left big tech to build something bigger: @AtomicAICo . He’s now leading the charge to decode RNA drug discovery with machine learning and structural biology. Catch his talk at #SynBioBeta on May 7 at 2:15 PM in San Jose: “AI x RNA: Foundation Models
0
5
5
We’re heading to Washington, D.C., tomorrow to join policymakers, technologists & industry leaders at the AI+ Biotechnology Summit. We are excited to be part of the conversation around shaping a national strategy for #AI-driven biotech innovation & security.
0
0
0
What will it take to unlock the full potential of RNA? In a new @Nature technology feature, @DianaMKwon speaks to our founding scientist Stephan Eismann about how we are pushing the boundaries of RNA structure prediction to design new therapeutics.
nature.com
Nature - AlphaFold’s highly accurate structural models transformed protein biology,but RNA lags behind.
0
0
4
Join me in South San Francisco on April 2 at Biocom California’s Converge Summit where I’ll be participating on the Latest Advancements in Drug Discovery panel. #ConvergeSummit:
app.sosha.ai
0
0
1
Atomic AI is about more than just generative #AI. Listen to Founder & CEO @raphaeljlt explain the company's four-prong approach to transforming RNA #drugdiscovery in this #JPM2025 interview clip. ▶️ Learn more: https://t.co/ICkrgL8y1S
0
0
3
#TBT to #JPM2025, where Atomic AI Founder & CEO @raphaeljlt sat down to discuss how the company is applying AI technologies that have transformed protein #drugdiscovery into the #RNA world, pushing forward a new frontier of RNA targeted medicine design.
0
0
4
GREAT NEWS: Atomic AI has been named one of "𝗙𝗶𝘃𝗲 𝗦𝗺𝗮𝗹𝗹 𝗕𝗶𝗼𝘁𝗲𝗰𝗵𝘀 𝘁𝗼 𝗪𝗮𝘁𝗰𝗵." A huge thank you to @pharmasalmanac, as well as our team, partners & supporters. 2025 is going to be a great year! 📰 Check out the full list: https://t.co/FnzDd4beUe
0
0
3
How will Atomic AI's novel combination of AI and structural biology accelerate #drugdiscovery and overcome some of the current challenges in #drugdevelopment? Founder & CEO @raphaeljlt explains the company's innovative approach with @craigss of @Eyeon_AI: https://t.co/DKKV5lMVxN
0
0
2
🎉 Exciting news! Atomic AI’s 𝗔𝗧𝗢𝗠-𝟭 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺 has been nominated as one of @medicine_maker’s standout innovations of 2024! 🌟 🗳️ Voting is open until January—please help us bring this honor home! https://t.co/PrTHjUBES6
0
0
3
Heading to Seattle for the @AACR special conference on RNAs as Drivers, Targets & Therapeutics in Cancer? Atomic AI CSO Manjunath Ramarao will be participating in the Nov. 17 plenary on Emerging RNA Technologies. Don't miss his 11:30 a.m. presentation! #aacrRNA24
0
0
3
How will Atomic AI's novel combination of AI and structural biology accelerate #drugdiscovery and overcome some of the current challenges in #drugdevelopment? Founder & CEO @raphaeljlt explains the company's innovative approach with @craigss of @EyeOn_AI: https://t.co/qbZJOBz2Rd
0
3
6